Immunoprofiling of cytokines, chemokines, and growth factors in female patients with systemic lupus erythematosus- a pilot study.
Laila A DamiatiIuliana DenetiuSami BahlasSamar DamiatiPeter Natesan PushparajPublished in: BMC immunology (2023)
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease affecting different organ systems. This study aimed to determine the concentrations of 30 different human cytokines, chemokines, and growth factors in human plasma to understand the role of these markers in the pathogenicity of SLE using Luminex Multiple Analyte Profiling (xMAP) technology. Plasma samples were obtained from patients with SLE (n = 28), osteoarthritis (OA) (n = 9), and healthy individuals (n = 12) were obtained. High levels of TNF, IL-6, IFN-γ, INF-α, IL-4, IL-5, IL-13, IL-8, IP-10, MIG, MCP-1, MIP-1β, GM-CSF, G-CSF, EGF, VEGF, IL-12, IL-1RA, and IL-10 was detected in SLE patients compared with the OA and healthy control groups. xMAP analysis has been used to address the differential regulation of clinical heterogeneity and immunological phenotypes in SLE patients. In addition, complete disease phenotyping information along with cytokine immune profiles would be useful for developing personalized treatments for patients with SLE.
Keyphrases
- systemic lupus erythematosus
- disease activity
- end stage renal disease
- rheumatoid arthritis
- chronic kidney disease
- ejection fraction
- endothelial cells
- newly diagnosed
- prognostic factors
- single cell
- multiple sclerosis
- immune response
- peritoneal dialysis
- escherichia coli
- staphylococcus aureus
- interstitial lung disease
- systemic sclerosis
- vascular endothelial growth factor
- cerebrospinal fluid